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Background: The growing utilization of total joint replacement will increase the frequency of its complications,
including periprosthetic fracture. The prevalence and risk factors of periprosthetic fracture require further study,
particularly over the course of long-term follow-up. The objective of this study was to estimate the prevalence and
risk factors for periprosthetic fractures occurring in recipients of total hip replacement.
Methods: We identified Medicare beneficiaries who had elective primary total hip replacement (THR) for non-fracture
diagnoses between July 1995 and June 1996. We followed them using Medicare Part A claims data through 2008. We
used ICD-9 codes to identify periprosthetic femoral fractures occurring from 2006–2008. We used the incidence density
method to calculate the annual incidence of these fractures and Cox proportional hazards models to identify risk factors
for periprosthetic fracture. We also calculated the risk of hospitalization over the subsequent year.
Results: Of 58,521 Medicare beneficiaries who had elective primary THR between July 1995 and June 1996, 32,463
(55%) survived until January 2006. Of these, 215 (0.7%) developed a periprosthetic femoral fracture between 2006 and
2008. The annual incidence of periprosthetic fracture among these individuals was 26 per 10,000 person-years. In the
Cox model, a greater risk of periprosthetic fracture was associated with having had a total knee replacement (HR 1.82,
95% CI 1.30, 2.55) or a revision total hip replacement (HR1.40, 95% CI 0.95, 2.07) between the primary THR and 2006.
Compared to those without fractures, THR recipients who sustained periprosthetic femoral fracture had three-fold
higher risk of hospitalization in the subsequent year (89% vs. 27%, p < 0.0001).
Conclusion: A decade after primary THR, periprosthetic fractures occur annually in 26 per 10,000 persons and are
especially frequent in those with prior total knee or revision total hip replacements.
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Total hip replacement (THR) is a highly effective treatment
for advanced hip arthritis. It is an increasingly common
procedure, with more than 300,000 primary THRs per-
formed in the US every year [1]. As the number of patients
with prosthetic joints in place increases, a growing number
of individuals are at risk for implant-related complications,
including periprosthetic fracture [2-5]. This particular com-
plication is especially important and clinically relevant* Correspondence: jnkatz@partners.org
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unless otherwise stated.because it is typically costly, disabling and morbid. In fact,
over 80% of periprosthetic fractures needed to be treated
surgically in one large series [6].
It would be useful for patients who have had THR, as well
as their providers and families, to understand the risk and
subsequent clinical implications of sustaining a peripros-
thetic fracture. Prior estimates suggest that about 3.5% of
THR recipients may experience a periprosthetic fracture
over the first decade after THR [2]. Few studies have exam-
ined the prevalence of these fractures over longer-term
follow-up, and there is relatively little information on risk
factors for periprosthetic fracture. Limited evidence suggests
an increase in risk due to older age [2], peptic ulcer [7], car-
diovascular disease [7], and a loose implant [8,9].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and risk factors for periprosthetic femoral fractures in a
population-based cohort of patients ten to twelve years
following primary THR. A secondary objective was to as-
sess the effects of periprosthetic fracture on subsequent
health care utilization by determining the one-year risk of
hospital admission for THR recipients who developed
periprosthetic femoral fractures as compared with recipi-
ents who did not sustain a fracture. We hypothesized that




We identified Medicare beneficiaries who had elective pri-
mary THR, for non-fracture diagnoses, between July 1995
and June 1996. We followed this cohort in Medicare Part
A claims data through 2008. The selection of this cohort
has been described elsewhere [10,11]. We used ICD-9
diagnosis codes to identify periprosthetic femoral fractures
for the period from 2006–2008. The ICD-9-CM code for
periprosthetic fracture (996.44) was introduced in Octo-
ber, 2005, which is why we examine fractures starting in
2006. The ICD-9 code does not identify the side (right vs.
left) of the fracture. We excluded patients with claims for
periprosthetic fracture that included surgical procedure
codes for the knee, tibia/fibula, humerus, radius/ulna, or
shoulder in the absence of any procedure codes for the
hip. We also identified all hospitalizations in the cohort of
THR recipients occurring in 2006–2008. For this analysis
we also excluded non-periprosthetic femoral fractures.
Analyses
We used the incidence density method to calculate the
annual incidence of periprosthetic femoral fractures.
Time “at risk” was defined from the beginning of obser-
vation (January 2006) to one of the three events, which-
ever occurred first: 1) death, 2) periprosthetic fracture,
or 3) end of the observation period (December 2008).
Once the patient reached one of these endpoints, obser-
vation ceased.
We used multivariate Cox proportional hazards models
to identify risk factors for periprosthetic fractures. Factors
examined included sex, age at follow-up in 2006 (75–80
vs. >80), race (white vs. non-white), eligibility for Medicaid
at time of primary THR (a proxy for low income), num-
ber of non-elective hospitalizations in the prior decade
(a proxy for comorbidity, categorized as 0–2, 3–5, >5
hospitalizations), and having had a primary or revision
hip or knee replacement after the index THR in 1995–
96. Note that with regard to age, all cohort members
were at least 75 years old in 2006 since they underwent
THR as Medicare beneficiaries (and thus were at least
65 years old) in 1995–96.In order to evaluate a prior observation that peptic ulcer
and cardiovascular disease were associated with peripros-
thetic fracture [7,12], we also identified subjects who had
prior admissions (from 1995–2005) with diagnostic codes
for peptic ulcer disease (codes 531 through 535) and car-
diovascular disease (codes 401 through 438).
We performed additional analyses to examine the conse-
quences of these fractures for resource utilization over the
subsequent year. For patients who had a periprosthetic
femoral fracture in 2006 or 2007, we calculated the risk of
hospitalization (to acute care, including acute rehabilitation
facilities) over the year following the fracture. For compari-
son, we also calculated the one-year hospitalization risk for
patients who did not have a femoral fracture in 2006 or
2007 from a randomly selected start date in 2006–2007. To
identify the effect of periprosthetic fracture independent of
age, sex and comorbidity, we ran a logistic regression with
hospitalization as the dependent variable and periprosthetic
fracture, as well as age, sex and Charlson comorbidity score
as independent variables. We also examined the first-listed
diagnosis on these admissions.
All analyses were done using SAS version 9.1.3. The
study was approved by the Partners HealthCare Human
Investigation Committee. Patient consent is not re-
quired to use administrative data provided proper pro-
cedure is followed. The investigators completed Data




Of 58,521 Medicare beneficiaries who had elective primary
THR between July 1995 and June 1996, 32,463 (55%) sur-
vived until January 2006. Their mean age was 82.5 and
67% of them were female (Table 1).
Incidence and risk factors
Between 2006 and 2008, 215 (0.7%) patients developed a
periprosthetic proximal femoral fracture, for an annual
incidence of 26 per 10,000 person-years.
The multivariate model identified having had a total
knee replacement between the index THR and 2006 as a
risk factor for periprosthetic fracture (HR 1.82, 9% CI 1.30,
2.55) as well as a revision total hip replacement between
the primary THR and 2006 (HR 1.40, 95% CI 0.95, 2.07;
Table 2). In the multivariate model, we did not observe an
increased risk of periprosthetic fracture associated with car-
diovascular disease (HR 0.87, 95% CI 0.62, 1.23) or with
peptic ulcer disease (HR 0.98, 95% CI 0.62, 1.54).
Subsequent hospitalization
We calculated the risk of hospitalization over the next
year for those cohort members who had periprosthetic
fracture in 2006–2007 as well as for subjects who did not
Table 2 Factors associated with risk of periprosthetic and
non-periprosthetic femoral fracture in 2006–2008 among







>80 1.26 (0.96, 1.67)
Sex:




3-5 0.94 (0.69, 1.29)
>5 1.06 (0.72, 1.57)
Hip or knee replacements after index THR
and before 2006:
Primary total hip replacement
No 1.0
Yes 1.04 (0.75, 1.42)
Primary total knee replacement
No 1.0
Yes 1.82 (1.30, 2.55)
Revision hip or knee replacement
No 1.0
Yes 1.40 (0.95, 2.07)
*Adjusted for factors on table and Medicaid eligibility; race.
not analyzed because there were too few non-whites.
Table 1 Demographic characteristics of Medicare recipients
who had periprosthetic fracture or no fracture in
2006–2008 following primary THR in 1995-1996
Characteristic Status in 2006-2008
Periprosthetic




75-80 (%) 81 (38%) 12,548 (40%)
> 80 (%) 134 (62%) 18,895 (60%)
Sex
Female (%) 139 (65%) 20,887 (66%)
Male (%) 76 (35%) 10,556 (34%)
Race
White (%) 208 (98%) 29,556 (95%)
Non-white (%)* 5 (2%) 1,601 (5%)
Mean number of hospitalizations
in 1995–2006 (range)
3.5 (0–20) 3.4 (0–43)
Mean number of hip or knee
replacements after index
THR and before 2006
0.49 (0–3) 0.38 (0–4)
*296 missing race.
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selected date. Compared to those without fractures, THR
recipients who sustained a periprosthetic femoral fracture
had three-fold higher risk of at least one hospitalization in
the subsequent year (89% vs. 27%, p < 0.0001). The risk of
hospitalization associated with periprosthetic fracture per-
sisted after adjustment for age, sex and comorbidity score
(OR 23.0, 95% CI 15.0, 35.2). . Seventeen percent of the
admissions among fracture patients were for medical rea-
sons and the remainder for acute rehabilitation and other
fracture related indications.
Discussion
Total hip replacement is among the most successful med-
ical advances of the twentieth century, relieving pain and
improving functional status in approximately 90% of THR
recipients [13]. Along with their new implants, however, pa-
tients who undergo THR take on the risks of several serious
implant-related complications including dislocation, infec-
tion and periprosthetic fracture. The latter is perhaps the
least well studied of these important complications and
may be especially morbid, costly and disabling.
We evaluated the risk of periprosthetic fracture in a
population-based study of Medicare recipients undergoing
primary THR in 1995–1996. We estimated that the inci-
dence of periprosthetic fracture among these individuals,
who had THR about ten years earlier, was 26 per 10,000
person years. We observed that a prior knee replacements
or revision THR were associated with greater risk of peri-
prosthetic fracture, whereas typical risk factors for osteo-
porosis (e.g. older age, female sex) were not associatedwith the risk of these fractures. Periprosthetic fractures
were associated with considerable subsequent health care
resource utilization, with three-fold higher risk of subse-
quent hospitalization than experienced by THR recipients
of the same age who did not have a femoral fracture.
Ours is the first US population-based study of peripros-
thetic fracture and the first study to our knowledge that
focuses on the risk of these fractures many years after the
hip replacement surgery. Thus our estimates capture the
longer-term risk of living with a hip implant, as distinct
from the perioperative risk of undergoing hip replacement
surgery. Our work complements prior studies that have
examined periprosthetic fractures in the Swedish [8,9] and
Finnish [4] Hip Registers and large single center registries
[7,14]. It is difficult to compare risks of fracture across
these studies because of differences in patient age and the
timing of the follow-up window in relation to the primary
THR. Our findings suggest that the higher earlier risk of
these fractures in the perioperative period diminishes con-
siderably over long term follow up. Our findings show that
in this older age group, men and women have similar risk
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retain a high index of suspicion of periprosthetic fracture
in an older patient with a compatible history even in the
absence of traditional osteoporotic risk factors. The in-
creased risk associated with concomitant knee replace-
ment and revision hip replacement may relate to the
mechanical stiffness associated with multiple implants, es-
pecially on the same limb. Singh and colleagues found that
a history of peptic ulcer disease and of heart disease were
risk factors for periprosthetic fracture. We were not able
to confirm this observation, although our comorbidity
data were derived from inpatient claims, which are likely
insensitive indicators, particularly of peptic ulcer disease.
As with any analysis of claims data, our study was limited
by potential misclassification in the outcome (periprosthetic
fracture). Also, we were unable to perform analyses for
periprosthetic fracture for years prior to 2006, when the
codes for these fractures were created. We were unable to
elicit several clinical details that might influence risk of
periprosthetic fracture such as whether the implant was
cemented or uncemented and we did not have access to
pharmacy data, which might have shed light on the role of
medications that increase risk of falls and treatments for
osteoporosis.
Conclusion
We conclude that periprosthetic fracture occurs in about
one in 400 THR recipients per year once these patients
are 10 years out from their hip replacement. These data
will help clinicians as they portray to patients and their
families the long-term concerns associated with living with
a hip implant. The message is that periprosthetic fractures
are relatively rare, though more frequent in patients with
multiple implants. Further, these fractures are typically as-
sociated with the need for considerable subsequent med-
ical care, as they are accompanied by a much greater risk
hospitalization in the subsequent year than experienced by
THR recipients who did not have hip fracture.
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